Gufic Biosciences Ltd - 509079 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE filing · raw filing ↗
2 Sep 2026
⚑ Filing
Gufic Biosciences Ltd - 509079 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Promotion And Change In Designation Of Senior Management PersonnelBSE filing · raw filing ↗
Gufic Biosciences Ltd - 509079 - Intimation Of Record Date For Final Dividend And 42Nd Annual General MeetingBSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Gufic Biosciences Ltd - 509079 - Shareholders Meeting - 42Nd Annual General Meeting Of The Company Scheduled To Be Held On Friday, September 04, 2026BSE filing · raw filing ↗
Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026BSE filing · raw filing ↗
7 Aug 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
Q4 FY26 results filed — revenue ₹252 Cr (+22.8% YoY), PAT ₹22 Cr (+183.6% YoY)NSE filing · raw filing ↗
25 May 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
Ex-date 22 Sep 2025
⚑ Corp action
Dividend — ₹0.10 per shareNSE filing · record 22 Sep 2025
Ex-date 21 Sep 2023
⚑ Corp action
Dividend — ₹0.10 per shareNSE filing
Ex-date 24 Aug 2022
⚑ Corp action
Dividend — ₹0.10 per shareNSE filing
Ex-date 9 Sep 2021
⚑ Corp action
Dividend — ₹0.10 per shareNSE filing
Ex-date 3 Nov 2020
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 20 Sep 2019
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 19 Sep 2018
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 28 Aug 2017
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 19 Sep 2016
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
Ex-date 22 Sep 2015
⚑ Corp action
Dividend — ₹0.05 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
